Hormone therapy, dementia, and cognition: The Women's Health Initiative 10 years on

Climacteric

Volumn 15, Issue 3, 2012, Pages 256-262

  Maki, P M ^a   Henderson, V W ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

ALZHEIMER'S DISEASE; COGNITION; DEMENTIA; ESTROGEN; HORMONE THERAPY; MEMORY; MENOPAUSE; PROGESTOGEN; REVIEW; SELECTIVE ESTROGEN RECEPTOR MODULATOR; WOMEN'S HEALTH INITIATIVE

Indexed keywords

CALCIUM; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ISOFLAVONE DERIVATIVE; LASOFOXIFENE; MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE; RALOXIFENE; TAMOXIFEN; TIBOLONE; VITAMIN D;

ALZHEIMER DISEASE; BRAIN SIZE; CIMICIFUGA RACEMOSA; CLIMACTERIUM; CLINICAL TRIAL (TOPIC); COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL (TOPIC); DEMENTIA; DIET SUPPLEMENTATION; DRUG MEGADOSE; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HORMONAL THERAPY; HOT FLUSH; HUMAN; HYSTERECTOMY; LOW DRUG DOSE; LOW FAT DIET; MENTAL TEST; META ANALYSIS (TOPIC); MILD COGNITIVE IMPAIRMENT; MULTICENTER STUDY (TOPIC); NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RED CLOVER; REVIEW; RISK FACTOR; VERBAL MEMORY; VITAMIN SUPPLEMENTATION; WORKING MEMORY;

AGED; AGING; ALZHEIMER DISEASE; COGNITION; COGNITION DISORDERS; DEMENTIA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEDROXYPROGESTERONE ACETATE; MEMORY; MIDDLE AGED; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WOMEN'S HEALTH;

EID: 84861405815     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2012.660613     Document Type: Review

References (67)

1. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33 (Pubitemid 34761611)
2. Anderson GL, Limacher M, Assaf AR , et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-12 (Pubitemid 38489892)
3. Plassman BL, Langa KM, Fisher GG , et al. Prevalence of dementia in the United States: the Aging, Demographics, and Memory Study. Neuroepidemiology 2007;29:125-32 (Pubitemid 350191430)
4. Lobo A, Launer LJ, Fratiglioni L , et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54 (Suppl 5):S4-9 (Pubitemid 30390598)
5. Larson EB, Shadlen MF, Wang L , et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 2004;140:501-9
6. Launer LJ, Andersen K, Dewey ME, et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. Neurology 1999;52:78-84 (Pubitemid 29044403)
7. Plassman BL, Langa KM, McCammon RJ , et al. Incidence of dementia and cognitive impairment, not dementia in the United States. Ann Neurol 2011;70:418-26
8. Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol 2002;59:1589-93
9. Henderson VW, Buckwalter JG. Cognitive deficits of men and women with Alzheimer's disease. Neurology 1994;44:90-6 (Pubitemid 24029436)
10. Ripich DN, Petrill SA, Whitehouse PJ, Ziol EW. Gender differences in language of AD patients: a longitudinal study. Neurology 1995;45:299-302
11. Tang M-X, Jacobs D, Stern Y , et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-32 (Pubitemid 26267873)
12. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer's disease. Arch Intern Med 1996;156: 2213-17 (Pubitemid 26361914)
13. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Agespecific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 2000;54:2072-7 (Pubitemid 30397204)
14. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer's disease in older women: the Cache County study. JAMA 2002;288:2123-9 (Pubitemid 35265379)
15. Hogervorst E, Williams J, Budge M, Riedel W, Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 2000;101:485-512
16. LeBlanc ES, Janowsky J, Chan BKS, Nelson HD. Hormone replacement therapy and cognition: systematic review and metaanalysis. JAMA 2001;285:1489-99 (Pubitemid 32221898)
17. Liu L, Zhao L, She H, et al. Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo. Endocrinology 2010;151:5782-94
18. Nilsen J, Deng J, Brinton RD. Impact of clinically relevant progestins on the neural effects of estradiol and the signaling pathways involved. Drug News Perspect 2005;18:545-53 (Pubitemid 43251105)
19. Morrison JH, Brinton RD, Schmidt PJ, Gore AC. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J Neurosci 2006;26:10332-48 (Pubitemid 44564581)
20. Henderson VW, Watt L, Buckwalter JG. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology 1996;21:421-30 (Pubitemid 26276650)
21. Schneider LS, Farlow MR, Henderson VW, Pogoda JM. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 1996;46:1580-4 (Pubitemid 26185775)
22. Doraiswamy PM, Bieber F, Kaiser L, Krishnan KR, Reuning-Scherer J, Gulanski B. The Alzheimer's disease assessment scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials. Neurology 1997;48:1511-17
23. Henderson VW, Paganini-Hill A, Miller BL , et al. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 2000;54:295-301 (Pubitemid 30078056)
24. Mulnard RA, Cotman CW, Kawas C , et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: arandomized controlled trial. JAMA 2000;283:1007-15 (Pubitemid 30112214)
25. Women's Health Initiative Study Group. Design of the Women'sHealth Initiative clinical trial and observational study. Control Clin Trials 1998;19:61-109
26. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study (WHIMS). JAMA 2003;289:2651-62 (Pubitemid 37430136)
27. Shumaker SA, Legault C, Kuller L , et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2947-58 (Pubitemid 38802684)
28. Rapp SR, Legault C, Henderson VW, et al. Subtypes of mild cognitive impairment in older postmenopausal women: the Women'sHealth Initiative Memory Study. Alzheimer Dis Assoc Disord 2010;24:248-55
29. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet 2006;367:1262-70
30. Coker LH, Hogan PE, Bryan NR, et al. Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMSMRI Study. Neurology 2009;72:125-34
31. Resnick SM, Espeland MA, Jaramillo SA, et al. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI study. Neurology 2009;72:135-42
32. Jaramillo SA, Felton D, Andrews L, et al. Enrollment in a brain magnetic resonance study: results from the Women's Health Initiative Memory Study Magnetic Resonance Imaging Study (WHIMS-MRI). Acad Radiol 2007;14:603-12 (Pubitemid 46551760)
33. Espeland MA, Tindle HA, Bushnell CA , et al. Brain volumes, cognitive impairment, and conjugated equine estrogens. J Gerontol A Biol Sci Med Sci 2009;64:1243-50
34. Lord C, Buss C, Lupien SJ, Pruessner JC. Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: a possible window of opportunity effect. Neurobiol Aging 2008;29:95-101 (Pubitemid 350102707)
35. Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 2002;288:2170-2 (Pubitemid 35276517)
36. Brett KM, Chong Y. H ormone Replacement Therapy: Knowledge and Use in the United States. Hyattsville, MD: National Center for Health Statistics, 2001
37. Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 2005;76:103-5 (Pubitemid 40013499)
38. Henderson VW, Espeland MA, Hogan PE , et al. Prior use of hormone therapy and incident Alzheimer's disease in the Women's Health Initiative Memory Study. Neurology 2007;68(Suppl 1):A205 (abstract)
39. Whitmer RA, Quesenberry CP, Zhou J, Yaffe K. Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol 2011;69:163-9
40. Henderson VW. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 2006;138:1031-9
41. Rocca WA, Cha RH, Waring SC, Kokmen E. Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984. Am J Epidemiol 1998;148: 51-62 (Pubitemid 28317545)
42. Yaffe K, Krueger K, Cummings SR, et al. Effect of raloxifene on the prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry 2005;162:683-90 (Pubitemid 40489129)
43. Resnick SM, Coker LH, Maki PM, Rapp SR, Espeland MA, Shumaker SA. The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials 2004;1:440-50
44. Resnick SM, Maki PM, Rapp SR , et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 2006;91:1802-10
45. Resnick SM, Espeland MA, An Y , et al. Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy. J Clin Endocrinol Metab 2009; 94:4152-61
46. Grady D, Yaffe K, Kristof M, Lin F, Richards C, Barrett-Connor E. Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am JMed 2002;113:543-8 (Pubitemid 35379908)
47. Linn RT, Wolf PA, Bachman DL , et al. The ' preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol 1995;52:485-90
48. Tierney MC, Yao C, Kiss A, McDowell I. Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 2005;64:1853-9 (Pubitemid 40800697)
49. Yaffe K, Vittinghoff E, Ensrud KE , et al. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch Neurol 2006;63:945-50 (Pubitemid 44036294)
50. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST). Am J Obstet Gynecol 2005;192:387-93 (Pubitemid 40214969)
51. Almeida OP, Lautenschlager NT, Vasikaran S, Leedman P, Gelavis A, Flicker L. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life. Neurobiol Aging 2006; 27:141-9 (Pubitemid 41627958)
52. Pefanco MA, Kenny AM, Kaplan RF, et al. The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women. J Am Geriatr Soc 2007;55:426-31 (Pubitemid 46328120)
53. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13:345-57
54. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485-95 (Pubitemid 23015018)
55. Maki PM, Sundermann E. Hormone therapy and cognitive function. Hum Reprod Update 2009;15:874-86
56. Joffe H, Hall JE, Gruber S , et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, doubleblind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 2006;13:411-22
57. Maki PM, Gast MJ, Vieweg AJ, Burriss SW, Yaffe K. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology 2007;69:1322-30 (Pubitemid 47482446)
58. Maki PM, Rubin LH, Fornelli D , et al. Effects of botanicals and combined hormone therapy on cognition in postmenopausal women. Menopause 2009;16:1167-77
59. Yaffe K, Krueger K, Sarkar S, et al. Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med 2001;344:1207-13 (Pubitemid 32319495)
60. Jacobsen DE, Samson MM, Emmelot-Vonk MH, Verhaar HJ. Raloxifene improves verbal memory in late postmenopausal women: a randomized, double-blind, placebo-controlled trial. Menopause 2010;17:309-14
61. Neele SJ, Rombouts SA, Bierlaagh MA, Barkhof F, Scheltens P, Netelenbos JC. Raloxifene affects brain activation patterns in postmenopausal women during visual encoding. J Clin Endocrinol Metab 2001;86:1422-4 (Pubitemid 32323038)
62. Goekoop R, Barkhof F, Duschek EJ, et al. Raloxifene treatment enhances brain activation during recognition of familiar items: apharmacological fMRI study in healthy elderly males. Neuropsychopharmacology 2006;31:1508-18
63. Legault C, Maki PM, Resnick SM, et al. Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene. J Clin Oncol 2009;27:5144-52
64. Espeland MA, Shumaker SA, Limacher M , et al. Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition. J Womens Health (Larchmt) 2010;19:371-9
65. Espeland M, Rapp S, Shumaker S , et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women'sHealth Initiative Memory Study. JAMA 2004;291:2959-68 (Pubitemid 38802685)
66. Resnick SM, Espeland MA, Jaramillo SA, et al. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study. Neurology 2009;72:135-42
67. Brinton RD. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann NY Acad Sci 2005;1052:57-74 (Pubitemid 41338958)